Oxana K. Pickeral, Ph.D., MBA

Dr. Oxana Pickeral is a seasoned executive with over 20 years operational, management consulting, and technology innovation experience involving commercial, government, and not-for-profit enterprises. She focuses on healthcare and life sciences innovation including healthcare analytics and the infusion of enabling technology into medical devices as part of the internet of things. Her industry experience includes: biomedical R&D, business development, alliance management, portfolio management, public-private partnerships, technology transfer, strategic planning and executive leadership.

Oxana is currently serving as the Board Chair and the Chief Operating Officer at HealthyWomen. She is also President of BioVenture LLC, a strategy and operations consultancy, and an advisor to Springboard Enterprises. Previously she led the Life Sciences Practice and the Medical Product Development capability area at Booz Allen, applying her business and product innovation expertise to a variety of strategy and operations projects worldwide on behalf of government, nonprofit, and industry clients. Prior to joining Booz Allen, she helped establish the new Experimental Therapeutics Program at the National Cancer Institute, NIH and led related portfolio and co-development alliance management activities; led bioinformatics and strategic marketing projects at Human Genome Sciences, Inc.; conducted computational biology research and tools development at NIH.

Oxana earned MBA in General Management and PhD in Human Genetics, both from Johns Hopkins University, and later taught the biomedical MBA cohort as a faculty member of Johns Hopkins' Carey Business School.


Suffering From Chronic Pain as a Black Woman

Bias can lead to disparities in diagnosis and treatment of Black women with chronic pain

Chronic Care Issues

Your Child’s Vaccines: What You Need to Know About Catching Up During the COVID-19 Pandemic

Vaccination rates dropped by as much as 60% in some parts of the country due to COVID-19. It's time to get back on track

Prevention & Screenings

Corralling the Facts on Herd Immunity

The effectiveness of herd immunity is a hotly debated topic. Time to separate fact from fiction

Prevention & Screenings